Transarterial chemoembolization in combination with programmed death-1/programmed cell death-ligand 1 immunotherapy for hepatocellular carcinoma: A mini review
- Resource Type
- Review Article
- Source
- In
iLIVER December 2022 1(4):225-234 - Subject
- Language
- ISSN
- 2772-9478